Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Matthew F. Wszolek
Based on 14 articles published since 2008
||||
Expertise Level
The expertise of Matthew F. Wszolek ranks in the Graphical view (beta)
Uncounted papers?
Aliases Wszolek, Matthew   ·   Wszolek, Matthew F
Work Locations
Details
Most likely:    Harvard University   Contact    
2018
  • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Radiation Oncology Branch, Center for Cancer Research, NIH, Bethesda, MD, USA. · Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 29511347
  • Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Biostatistics, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 28870862
2017
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA; Harvard Radiation Oncology Program, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. · Department of Urology, Massachusetts General Hospital, Boston, MA, USA. · Division of Hematology-Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 28081860
  • Department of Urology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Department of Pathology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28040351
  • Department of Urology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, University Hospital, Bern, Switzerland. · The Programs in Experimental Therapeutics and Cancer Biology, The University of Texas-Graduate School of Biomedical Sciences, Houston, TX, USA. · Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27494900
2015
  • Department of Urology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. · Pubmed 25644153
Probable:    University of Texas Houston   Contact    
2017
  • Department of Urology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, University Hospital, Bern, Switzerland. · The Programs in Experimental Therapeutics and Cancer Biology, The University of Texas-Graduate School of Biomedical Sciences, Houston, TX, USA. · Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27494900
2014
  • Department of Urology, University of Virginia, Charlottesville, Virginia, California. · Department of Urology, University of Texas M.D. Anderson Cancer Center, Los Angeles, California. · University of Southern California Institute of Urology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California. · Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Los Angeles, California. · Department of Urology, University of Texas M.D. Anderson Cancer Center, Los Angeles, California. Electronic address: · Pubmed 23911605
2013
  • Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23507396
  • Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 23239884
  • Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22863868
Probable:    Lahey Burlington   Contact    
2011
  • Department of Urology, Lahey Clinic Medical Center, Burlington, MA 01805, USA. · Pubmed 19945312
2011
  • Department of Urology, Lahey Clinic, Burlington, MA, USA. · Pubmed 20735391
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Matthew F. Wszolek about Urinary Bladder Neoplasms:

  • PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. 2018
  • Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer. 2018
  • Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. 2017
  • Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy. 2017
  • Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. 2017
  • Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer. 2015
  • Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. 2014
  • Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer. 2013
  • The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. 2013
  • Plasma microRNA profiles for bladder cancer detection. 2013
Show List of Full Article Records
Google Searches

Learn more about Matthew F. Wszolek using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
University of Texas Houston
Lahey Burlington
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2018
  • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Radiation Oncology Branch, Center for Cancer Research, NIH, Bethesda, MD, USA. · Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 29511347
  • Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Biostatistics, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 28870862
2017
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA; Harvard Radiation Oncology Program, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. · Department of Urology, Massachusetts General Hospital, Boston, MA, USA. · Division of Hematology-Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 28081860
  • Department of Urology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Department of Pathology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28040351
  • Department of Urology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, University Hospital, Bern, Switzerland. · The Programs in Experimental Therapeutics and Cancer Biology, The University of Texas-Graduate School of Biomedical Sciences, Houston, TX, USA. · Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27494900
2015
  • Department of Urology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. · Pubmed 25644153
University of Texas Houston
2017
  • Department of Urology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, University Hospital, Bern, Switzerland. · The Programs in Experimental Therapeutics and Cancer Biology, The University of Texas-Graduate School of Biomedical Sciences, Houston, TX, USA. · Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27494900
2014
  • Department of Urology, University of Virginia, Charlottesville, Virginia, California. · Department of Urology, University of Texas M.D. Anderson Cancer Center, Los Angeles, California. · University of Southern California Institute of Urology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California. · Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Los Angeles, California. · Department of Urology, University of Texas M.D. Anderson Cancer Center, Los Angeles, California. Electronic address: · Pubmed 23911605
2013
  • Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23507396
  • Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 23239884
  • Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22863868
Lahey Burlington
2011
  • Department of Urology, Lahey Clinic Medical Center, Burlington, MA 01805, USA. · Pubmed 19945312
2011
  • Department of Urology, Lahey Clinic, Burlington, MA, USA. · Pubmed 20735391
Miscellaneous cities in Massachusetts
2010
Miscellaneous institutions in Boston
2009
  • Predictive Biosciences, Inc, Lexington, Massachusetts, USA. · Pubmed 19758628
Yearly article counts 023011302110
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.